These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7662428)

  • 41. [Cholestatic hepatitis associated with tenoxicam].
    Pascual AF; Jiménez Martos F; Rodríguez Moreno C
    Aten Primaria; 1995 Mar; 15(5):329. PubMed ID: 7734692
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug-induced hepatitis].
    Shimizu Y; Asada T; Nishikawa H; Iwane Y; Hamatani M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():538-44. PubMed ID: 18074598
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical studies of toxic hepatitis and identification of causative substances].
    Namihisa T; Ogiwara M; Kitami N; Yasuura S
    Nihon Rinsho; 1985 Jun; 43(6):1144-9. PubMed ID: 3900465
    [No Abstract]   [Full Text] [Related]  

  • 44. Idiosyncratic toxic hepatitis secondary to single dose of naproxen.
    Demirag MD; Ozenirler S; Goker B; Poyraz A; Haznedaroglu S; Ozturk MA
    Acta Gastroenterol Belg; 2007; 70(2):247-8. PubMed ID: 17715646
    [No Abstract]   [Full Text] [Related]  

  • 45. [Cholestatic and cytolytic hepatitis and acute kidney failure caused by pirprofen].
    Bentata Pessayre M; Callard P; Delzant G
    Ann Med Interne (Paris); 1986; 137(5):445. PubMed ID: 3813277
    [No Abstract]   [Full Text] [Related]  

  • 46. [Regressive fulminant hepatitis, acute pancreatitis and renal insufficiency after taking ketoprofen].
    Flamenbaum M; Abergel A; Marcato N; Zénut M; Kémény JL; Cassan P
    Gastroenterol Clin Biol; 1998 Nov; 22(11):975-6. PubMed ID: 9881281
    [No Abstract]   [Full Text] [Related]  

  • 47. [Toxic cholestatic hepatitis due to droxicam].
    Alguacil GF; García B; Martínez M; de Paco M
    Rev Clin Esp; 1993 Feb; 192(2):94-5. PubMed ID: 8460246
    [No Abstract]   [Full Text] [Related]  

  • 48. [Ketoprofen-induced acute hepatitis].
    Bonaventure C; Nancey S; Pont E; Michalet V; Chevalier M; Vial T; Taieb S; Claudel S; Flourie B; Descos L
    Gastroenterol Clin Biol; 2001; 25(6-7):716-7. PubMed ID: 11673741
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug-induced Sweet's syndrome by aceclofenac.
    Carvalho R; Fernandes C; Afonso A; Cardoso J
    Cutan Ocul Toxicol; 2011 Dec; 30(4):315-6. PubMed ID: 21506881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Exudative erythema multiforme with transition to a toxic epidermal necrolysis after taking aceclofenac (Beofenac)].
    Ludwig C; Brinkmeier T; Frosch PJ
    Dtsch Med Wochenschr; 2003 Mar; 128(10):487-90. PubMed ID: 12627339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac.
    Rhee YS; Nguyen T; Park ES; Chi SC
    Arch Pharm Res; 2013 May; 36(5):602-7. PubMed ID: 23475315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Toxic and autoimmune type I-like hepatitis and hyporegenerative anemia caused by bendazac].
    Alcalde M; García-Díaz M; Najarro F; Pascasio JM
    Rev Esp Enferm Dig; 1994 May; 85(5):404-5. PubMed ID: 8049115
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chronic active hepatitis due to bendazac].
    Rodríguez Rodríguez E; Prieto de Paula JM; Cancelo Suárez P; Echevarría Iturbe C
    Rev Clin Esp; 1994 Aug; 194(8):657-8. PubMed ID: 7938854
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
    Grau M; Guasch J; Montero JL; Felipe A; Carrasco E; Juliá S
    Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aceclofenac-induced acute tubulointerstitial nephritis in a patient with diabetes.
    Gupta M; Cruz SD; Nada R; Aggarwal P
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23682087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hepatic tolerance of aceclofenac].
    Marsicano LJ; Ocampo ME
    G E N; 1994; 48(4):250-5. PubMed ID: 7557281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Toxic hepatitis caused by droxicam].
    Caballería Rovira E; Aragó López JV; Massó Ubeda RM; Sanchís Closa A
    Med Clin (Barc); 1992 Jul; 99(6):239. PubMed ID: 1507923
    [No Abstract]   [Full Text] [Related]  

  • 58. [Droxicam-induced hepatitis: a report of 2 cases].
    Omar M; Mediavilla-García JD; Corrales Torres AJ; Guzmán M; Jiménez-Alonso J
    Rev Esp Enferm Dig; 1993 Oct; 84(4):277. PubMed ID: 8292443
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hepatitis caused by pirprofen (Rangasil). 3 cases].
    Fouin-Fortunet H; Lerebours E; Bernet J; Hemet J; Colin R
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):349-51. PubMed ID: 3488580
    [No Abstract]   [Full Text] [Related]  

  • 60. Another side effect of NSAIDs.
    Gay GR
    JAMA; 1990 Nov; 264(20):2677-8. PubMed ID: 2232046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.